Shandong Boan Biotechnology Balance Sheet Health
Financial Health criteria checks 3/6
Shandong Boan Biotechnology has a total shareholder equity of CN¥1.3B and total debt of CN¥396.2M, which brings its debt-to-equity ratio to 30%. Its total assets and total liabilities are CN¥2.3B and CN¥1.0B respectively.
Key information
30.0%
Debt to equity ratio
CN¥396.16m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥201.85m |
| Equity | CN¥1.32b |
| Total liabilities | CN¥1.00b |
| Total assets | CN¥2.32b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6955's short term assets (CN¥713.0M) exceed its short term liabilities (CN¥653.3M).
Long Term Liabilities: 6955's short term assets (CN¥713.0M) exceed its long term liabilities (CN¥350.2M).
Debt to Equity History and Analysis
Debt Level: 6955's net debt to equity ratio (14.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6955's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 6955 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6955 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.